Horizon Technology Finance Corporation
HRZNHorizon Technology Finance Corporation (HRZN) is a specialty finance company that provides private and public venture capital debt to technology, life sciences, and healthcare companies. Established in 2004, it focuses on funding early- to late-stage growth companies, often through secured loans and debt investments, supporting innovation and growth within the technology and healthcare sectors.
Dividend History
Investors can expect a dividend payout of $0.11 per share, scheduled to be distributed in 49 days on March 13, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 13, 2026 | $0.11 | 2026-02-17 | 2026-02-17 |
| February 13, 2026 | $0.11 | 2026-01-16 | 2026-01-16 |
| January 15, 2026 | $0.11 | 2025-12-17 | 2025-12-17 |
| December 16, 2025 | $0.11 | 2025-11-17 | 2025-11-17 |
| November 14, 2025 | $0.11 | 2025-10-16 | 2025-10-16 |
Dividends Summary
- Consistent Payer: Horizon Technology Finance Corporation has rewarded shareholders with 172 dividend payments over the past 16 years.
- Total Returned Value: Investors who held HRZN shares during this period received a total of $20.46 per share in dividend income.
- Latest Payout: The most recent dividend of $0.11/share was paid 8 days ago, on January 15, 2026.
- Yield & Schedule: HRZN currently pays dividends monthly with an annual yield of 19.73%.
- Dividend Growth: Since 2010, the dividend payout has decreased by 50.0%, from $0.22 to $0.11.
- Dividend Reliability: HRZN has maintained or increased its dividend for 25 consecutive payments.
Company News
Monroe Capital Corporation declared a $0.18 per share distribution for Q4 2025, payable on December 31, 2025. The company anticipates an Asset Sale with Monroe Capital Income Plus Corporation and a merger with Horizon Technology Finance Corporation in Q1 2026.
BioVaxys and Horizon Technology Finance Corp have executed an amendment to their Asset Purchase Agreement, lowering the capital raise milestone for BioVaxys and extending the licensing earn-out term.
Horizon Technology Finance Corporation (HRZN) reported lower-than-expected investment income and a decline in net asset value, causing its stock price to drop. Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by the company.
Net Power Inc. reported a decrease in cash and cash equivalents, leading to a 31.46% drop in its stock price. The company also announced the departure of its President, COO, and CFO, causing a further 5.75% decline in the stock price.
Pomerantz LLP is investigating claims on behalf of investors of RH, Horizon Technology Finance Corporation, and Gorilla Technology Group, Inc. due to concerns about potential securities fraud or other unlawful business practices.
